Malaria Breakthrough?
The most infamous, common mosquito disease is malaria, which plagues much of Sub-Saharan Africa, South and Southeast Asia, and Central and South America. Mosquito borne, malaria causes nearly 1,000,000 deaths around the globe each year.
Recently, a team of scientists based in Nigeria and working in seven Sub-Saharan African countries total, announced a promising breakthrough in their search for an effective vaccination that would protect individuals from the disease. At a recent forum held in Seattle, Washington and sponsored by the Bill and Melinda Gates Foundation, the team presented their findings from clinical trials of RTS, S, also known as Mosquirix. The trials, held in 11 sites total, produced evidence that a series of three vaccinations of Mosquirix severely reduces malaria contraction in children. About 6,000 children have tested the vaccine so far, and their progress has been monitored for one full year.
While these results have been met with much jubilation by the World Health Organization and other global health advocates, its release is not expected until 2015, and it would be capable of making slow strides in the fight against malaria. Although it seems to have been proven to decrease malaria contraction definitely, it has produced less impressive results than similar vaccines against polio or measles, which have virtually eradicated the diseases themselves. Effective permeation of Sub-Saharan African populations with Mosquirix would require significant and efficient government involvement and a re-allocation of government funds and resources to truly tackle the problem. Furthermore, this vaccine would only help reduce malaria rates; it does not affect other diseases caused by mosquitoes, such as dengue fever, which are plaguing tropical areas with alarming rates of increase.
However, this breakthrough is promising. Global health professionals and governing agents from malaria-stricken countries should recognise the value of comprehensive research and trials and should continue to invest time and funding into research for the prevention of mosquito borne diseases. As diseases evolve and develop, research must continue to remain one step ahead. Also, the WHO and other international global health bodies should help develop a plan to finance a mass vaccination process so that these products can be made affordable and reachable for even the most destitute portions of the population. Hopefully malaria and other mosquito diseases will soon go the way of polio and be virtually eradicated
